Alphazyme

What Alphazyme does

Alphazyme, founded in 2018 and headquartered in Jupiter, Florida, is a biotechnology company that designs, manufactures, and supplies custom and catalog molecular biology enzymes for nucleic acid applications. Its product portfolio spans DNA polymerases (Taq, AlphaHiFi, KOD variants, Phi29, T4), RNA polymerases (T7, CleanScribe, SoloScript), ligases (T4, T7, T3, AlphaDR), nucleases, kinases, phosphatases, and reverse transcriptases, organized around three focus areas: next-generation sequencing, amplification/molecular diagnostics, and mRNA therapeutics / in vitro transcription (IVT). Core offerings are customizable on a royalty-free and license-free basis, not subject to RUO restrictions, and span RUO and GMP grades. The company operates a 19,000 sq ft ISO 13485:2016-certified manufacturing facility in Jupiter and added a 5,000 sq ft GMP facility in 2026 with Grade D / ISO 8 production suites, enabling integrated R&D-to-commercial scale supply from milligrams to kilograms.

Alphazyme generates revenue through three primary streams: unit-priced catalog enzyme sales (e.g., T4 RNA Ligase I at $218.40, KOD exo- at $338.80, HiFi DNA Polymerase at $55.15), quote-based custom enzyme development under multi-year contracts, and GMP-grade enzyme manufacturing for regulated biotech and pharmaceutical customers. Additional revenue is derived from licensing arrangements, including Optimer enzyme-modulating products licensed to/from Twist Bioscience and Aptamer Group. The company sells primarily through a direct e-commerce platform (alpha-zyme.com) supported by technical-sales engagement, targeting biotech and pharma companies ranging from start-ups to Fortune 100 firms, molecular diagnostics developers, and RNA therapeutics manufacturers.

Alphazyme operates as a wholly-owned subsidiary of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), alongside sister company TriLink BioTechnologies, and collaborates with TriLink on integrated IVT supply. Named enterprise customers and partners include TriLink BioTechnologies, Applied DNA Sciences (Linea RNAP scale-up), Twist Bioscience, and Aptamer Group. The company holds no disclosed patents or trademarks, and its strategic moat rests primarily on ISO 13485:2016 regulatory compliance, GMP capacity, proprietary differentiated enzymes (e.g., CleanScribe, SoloScript reducing dsRNA by up to 85% in IVT), and integration within the Maravai life-sciences tools ecosystem.

Name

Alphazyme

Legal name

Alphazyme LLC

Website

https://alpha-zyme.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Alphazyme is an ISO 13485:2016-certified U.S. manufacturer of custom and catalog molecular biology enzymes — polymerases, ligases, nucleases, and reverse transcriptases — serving biotech, molecular diagnostics, and mRNA therapeutics customers from RUO to GMP grade, as a wholly-owned subsidiary of Maravai LifeSciences.

Ownership category

akta.pro rank

Product category

Molecular Biology Enzymes and Biotech Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

akta.pro secondary industries

RNA Manufacturing & CMC (oligo synthesis, IVT, purification, formulation, QC) (HLAAADAF), Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)

Keywords

• Molecular biology enzymes
• Custom enzyme development
• GMP enzyme manufacturing
• DNA and RNA polymerases
• MRNA therapeutics reagents

Headquarters

HQ city

Jupiter

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Enzyme Product Sales: Alphazyme generates revenue through the sale of molecular biology enzymes to commercial customers, including standard catalog products and custom enzyme development. Products are sold with various specifications including RUO and GMP grades.
2. Licensing Agreements: Revenue from licensing Optimer enzyme-modulating products to partners such as Twist Bioscience and Alphazyme for applications including hot-start PCR.
3. GMP Enzyme Manufacturing: Revenue from manufacturing enzymes under GMP quality systems for regulated applications in biotechnology and pharmaceutical industries.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Alphazyme designs, develops, and manufactures high-quality, proprietary molecular biology enzymes — including polymerases, ligases, nucleases, reverse transcriptases, and capping enzymes — supplied to life-sciences R&D, molecular diagnostic, and biopharmaceutical customers. The company also offers custom enzyme development services and cGMP-grade enzyme manufacturing for mRNA therapeutics and other regulated applications.

Product overview

Alphazyme is a premier enzyme partner for molecular biology applications, offering a comprehensive portfolio of enzymes for Next-Generation Sequencing (NGS), Amplification Technologies/Molecular Diagnostics (MDx), and mRNA Therapeutics/In Vitro Transcription (IVT). The company provides customizable core products on a royalty-free and license-free basis, spanning DNA polymerases (including proprietary AlphaHiFi and KOD variants), RNA polymerases (T7 and SoloScript), ligases (T4, T7, T3), nucleases (exonucleases, endonucleases), and specialized enzymes for mRNA production (pyrophosphatase, RNase inhibitors, capping enzymes). Alphazyme operates ISO 13485:2016-certified manufacturing facilities in Jupiter, Florida—a 19,000 sq ft general facility and a new 5,000 sq ft GMP facility—enabling them to serve both research and regulated commercial applications from milligrams to kilograms scale.

Differentiator

Problem solved

Functional benefit

Brands

• CleanScribe: CleanScribe™ RNA Polymerase - a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA production by up to 85%.
• AlphaHiFi
• AlphaScribe
• AlphaDR Ligase
• AlphaRepair Mix
• AlphaUCER Mix
• SoloScript
• AlphaHiFi Hot Start

Products and services

• HiFi DNA Polymerase High-fidelity DNA polymerase enzyme for research and molecular biology workflows such as PCR, sequencing, and cloning; sold as a standalone catalog SKU to life-sciences R&D and diagnostic developers.
• HiFi Hot Start DNA Polymerase Hot-start version of Alphazyme's HiFi DNA polymerase for high-fidelity PCR with reduced non-specific amplification; sold to research and diagnostic developers as a catalog SKU.
• AlphaHiFi DNA Polymerase Alphazyme's proprietary high-fidelity DNA polymerase engineered for demanding molecular biology applications; sold to research and diagnostic developers as a catalog SKU.
• AlphaHiFi Hot Start DNA Polymerase Hot-start version of Alphazyme's AlphaHiFi DNA polymerase for high-fidelity PCR applications requiring reduced non-specific amplification; sold as a standalone catalog SKU.
• Taq DNA Polymerase Alphazyme's proprietary Taq DNA polymerase for standard PCR and molecular biology workflows; sold as a standalone catalog SKU to research and diagnostic developers.
• Taq Hot Start DNA Polymerase Hot-start version of Alphazyme's Taq DNA polymerase for PCR workflows requiring reduced non-specific amplification; sold as a standalone catalog SKU.
• Taq552 DNA Polymerase Engineered Taq-variant DNA polymerase for demanding molecular biology applications; sold as a standalone catalog SKU.
• KOD DNA Polymerase High-fidelity KOD-family DNA polymerase for demanding PCR and molecular biology workflows; sold as a standalone catalog SKU.
• KOD Hot Start DNA Polymerase Hot-start version of Alphazyme's KOD DNA polymerase for high-fidelity PCR with reduced non-specific amplification; sold as a standalone catalog SKU.
• KOD (exo-) DNA Polymerase Exonuclease-deficient KOD-family DNA polymerase for molecular biology workflows requiring labeled or blunt-end polymerization without degradation; sold as a standalone catalog SKU.
• T4 DNA Ligase Alphazyme's T4 DNA ligase for blunt- and sticky-end DNA ligation in cloning, library prep, and molecular biology workflows; sold as a standalone catalog SKU.
• T7 DNA Ligase Alphazyme's T7 DNA ligase for specific DNA ligation applications, including ligation in nucleic acid detection and molecular diagnostics workflows; sold as a standalone catalog SKU.
• T3 DNA Ligase Alphazyme's T3 DNA ligase for DNA ligation in research and molecular biology workflows; sold as a standalone catalog SKU.
• AlphaDR Ligase Alphazyme's proprietary engineered DNA ligase for diagnostics and research workflows requiring high specificity or activity beyond standard T4/T7 ligases; sold as a standalone catalog SKU.
• T4 RNA Ligase I Alphazyme's T4 RNA ligase I for RNA ligation applications including 3' modification of RNA, small RNA cloning, and RNA research workflows; sold as a standalone catalog SKU.
• T4 RNA Ligase II Alphazyme's T4 RNA ligase II for RNA-RNA ligation applications in RNA research and RNA sequencing workflows; sold as a standalone catalog SKU.
• AlphaScribe Reverse Transcriptase Alphazyme's proprietary engineered reverse transcriptase for cDNA synthesis, RNA detection, and RNA-seq first-strand synthesis; sold as a standalone catalog SKU.
• T7 RNA Polymerase T7 RNA polymerase for in-vitro transcription of RNA for research, RNA therapeutics, and biotechnology applications; sold as a standalone catalog SKU.
• CleanScribe RNA Polymerase (GMP) cGMP-grade CleanScribe RNA polymerase for in-vitro transcription in mRNA therapeutic manufacturing; sold as a standalone GMP-grade SKU to biopharmaceutical manufacturers.
• Wild-type T7 RNA Polymerase (GMP) cGMP-grade wild-type T7 RNA polymerase for in-vitro transcription in mRNA therapeutic manufacturing; sold as a standalone GMP-grade SKU to biopharmaceutical manufacturers.
• E. coli Inorganic Pyrophosphatase (GMP) cGMP-grade E. coli inorganic pyrophosphatase (PPase) for process-related use in mRNA and biopharmaceutical manufacturing; sold as a standalone GMP-grade SKU.
• DNase I (GMP) cGMP-grade DNase I for nucleic-acid removal during mRNA and biopharmaceutical manufacturing; sold as a standalone GMP-grade SKU.
• 2'-O-Methyltransferase (GMP) cGMP-grade 2'-O-methyltransferase for enzymatic mRNA methylation/capping in therapeutic mRNA manufacturing; sold as a standalone GMP-grade SKU.
• Vaccinia Capping Enzyme (VCE) (GMP) cGMP-grade Vaccinia capping enzyme for co-transcriptional or enzymatic mRNA capping in therapeutic mRNA manufacturing; sold as a standalone GMP-grade SKU.
• Exonuclease I Single-strand DNA-specific exonuclease for research and molecular biology workflows requiring removal of single-stranded DNA; sold as a standalone catalog SKU.
• Exonuclease III Exonuclease III for research workflows requiring directional degradation of double-stranded DNA from blunt or 5'-overhang ends; sold as a standalone catalog SKU.
• T7 Gene 6 Exonuclease T7 gene 6 exonuclease for research workflows requiring cleavage of DNA from 5' ends; sold as a standalone catalog SKU.
• Endonuclease VIII DNA glycosylase/lyase for research and molecular biology workflows requiring recognition and removal of damaged DNA bases; sold as a standalone catalog SKU.
• RNase R (truncated) Engineered truncated RNase R for research workflows requiring removal of linear RNA, useful in circular RNA and RNA purification applications; sold as a standalone catalog SKU.
• Custom Enzyme Development Service Service offering in which Alphazyme develops custom-engineered enzymes to a partner's specifications — activity, fidelity, specificity, or process fit — for life-sciences R&D and biopharmaceutical customers.
• GMP Enzyme Manufacturing Service Service offering for cGMP-grade manufacture and supply of enzymes for regulated mRNA therapeutics and biopharmaceutical manufacturing; ordered via quote, license, or supply agreement by biopharma manufacturers.

Quantifiable outcome

• CleanScribe RNA Polymerase reduces dsRNA by up to 85% in mRNA production
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Aptamer GroupcoreOEM/ Whitelabel/ Licensing Partner · 1 December 2025Licensing and supply agreements for enzyme-modulating Optimers, including products for hot-start PCR applications. Aptamer Group out-licensed enzyme-modulating Optimers to Alphazyme as part of their commercial strategy.
• Twist BiosciencecoreOEM/ Whitelabel/ Licensing Partner · 1 December 2025Licensing agreement for Optimer binders technology, enabling Twist Bioscience to access Alphazyme's enzyme products for their synthetic biology applications.
• TriLink BioTechnologiescoreStrategic or Co-development Partner · 25 September 2024Collaboration to launch CleanScribe RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA production by up to 85%, helping develop safer, more potent mRNA therapeutics.
• Applied DNA SciencescoreStrategic or Co-development Partner · 18 March 2024Scale-up manufacturing agreement for Applied DNA's proprietary Linea RNAP, progressing towards GMP Linea IVT production. Successful conclusion of manufacturing scale-up project delivered substantial improvement in Linea IVT platform economics.
• Dyadic InternationalminorOEM/ Whitelabel/ Licensing Partner · 28 September 2020Sub-licensing agreement for enzyme technology applications.

Scale indicators4 records

Recent moves7 records

Expansion highlights4 records

Emerging players

• Lucigen (now part of LGC): Specialty molecular biology enzyme and reagent supplier (acquired by LGC Biosearch Technologies), focused on PCR, NGS, and cloning enzymes — a smaller-scale specialist comparable to Alphazyme's enzyme customization niche.
• Twist Bioscience: Synthetic biology and DNA synthesis company that recently licensed Alphazyme binders for enzyme applications; while primarily known for DNA oligos and NGS panels, its enzyme-adjacent activities make it a relevant comparable.

Broad incumbents

• MilliporeSigma (Merck KGaA Life Science): Operates the Sigma-Aldrich and MilliporeSigma brands supplying molecular biology enzymes, IVT reagents, and bioprocessing inputs — overlapping with Alphazyme across RUO catalog and GMP biomanufacturing enzyme categories.
• Cytiva: Danaher-owned bioprocessing vendor offering enzymes and process inputs for nucleic-acid and mRNA manufacturing, including GMP-grade inputs — competing with Alphazyme's GMP enzyme line into CDMO and biopharma customers.
• Thermo Fisher Scientific: Broad life-sciences conglomerate whose Life Science Solutions segment markets a wide enzyme, polymerase, and molecular biology reagent portfolio, including GMP-grade enzymes that compete with Alphazyme's new GMP offerings.

Direct peers

• GenScript Biotech: Global life-science tools provider offering custom enzymes, PCR reagents, and gene synthesis products serving biotech and pharma — overlapping with Alphazyme in custom molecular biology enzyme development and gene-technology services.
• Codexis: Engineered enzyme developer (and an existing Alphazyme strategic partner) whose CodeEvolver platform produces customized polymerases and biocatalysts — a direct comparability in protein engineering and custom enzyme delivery.
• Promega Corporation: Privately held life-science tools manufacturer offering an extensive portfolio of PCR, RT-qPCR, and nucleic acid enzymes/reagents, overlapping Alphazyme's amplification/MDx and NGS enzyme lines.
• Integrated DNA Technologies (IDT): Danaher subsidiary providing custom nucleic acids and associated enzymes for genomics, molecular diagnostics, and synthetic biology — competing directly with Alphazyme in NGS library prep and amplification reagent markets.
• New England Biolabs: The premier independent molecular biology enzyme supplier, with the deepest catalog of polymerases, ligases, and nucleases for PCR, NGS, and mRNA applications — directly competing with Alphazyme across RUO and commercial-grade enzyme SKUs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/alphazyme-llc/posts/?feedView=all

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alphazyme